Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose versus moderate-dose clofibrate for neonatal jaundice
IRCT2012092910933N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of clofibride in jaundice and hyperbilirubinemia (2 arms), sponsored by Hamadan University of Medical Sciences. Started Sep 2008; status: completed.
02
Drugs
clofibride
03
Conditions
jaundicehyperbilirubinemia
Beyond the preview
Go deeper on IRCT2012092910933N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012092910933N1.